Search hospitals > Iowa > Des Moines
Mercy Medical Center - Des Moines
Claim this profileDes Moines, Iowa 50314
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Relapse
Conducts research for Lung Cancer
Conducts research for Cervical Adenocarcinoma
388 reported clinical trials
6 medical researchers
Summary
Mercy Medical Center - Des Moines is a medical facility located in Des Moines, Iowa. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Relapse, Lung Cancer, Cervical Adenocarcinoma and other specialties. Mercy Medical Center - Des Moines is involved with conducting 388 clinical trials across 537 conditions. There are 6 research doctors associated with this hospital, such as Richard L. Deming, Mehmet S. Copur, Atul Chawla, MD, and Robert Hoyt, MD.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
Top PIs
Richard L. DemingMercy Medical Center - Des Moines6 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Breast Cancer
178 reported clinical trials
242 drugs studied
Mehmet S. CopurBethesda North Hospital13 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
3 reported clinical trials
14 drugs studied
Atul Chawla, MDMercy Hospital Medical Center7 years of reported clinical research
Studies Stroke
Studies Mitral Regurgitation
3 reported clinical trials
3 drugs studied
Robert Hoyt, MDIowa Heart Center6 years of reported clinical research
Studies Ear Stimulation
Studies Atrial Fibrillation
3 reported clinical trials
4 drugs studied
Clinical Trials running at Mercy Medical Center - Des Moines
Breast Cancer
Lung Cancer
Cancer
Parotid Gland Cancer
Breast cancer
Multiple Myeloma
Non-Small Cell Lung Cancer
Bladder Cancer
Squamous Cell Carcinoma
Skin Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Mercy Medical Center - Des Moines?
Where is Mercy Medical Center - Des Moines located?
Who should I call to ask about financial aid or insurance network?
What insurance does Mercy Medical Center - Des Moines accept?
What awards or recognition has Mercy Medical Center - Des Moines received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.